‘Pivotal’ new prostate screening trial could nearly HALVE deaths from the disease, scientists hope [Video]

A “PIVOTAL” prostate cancer screening trial could nearly halve deaths from the disease, scientists hope.

Prostate Cancer UK is starting a government-funded experiment to find the best way to check blokes for tumours.

It is the most common type of cancer in men, with 52,000 cases and 12,000 deaths per year in the UK.

More than 300,000 men will be involved in trials of blood tests, MRI scans and genetic screening to see how best to detect cancer cells early.

It is hoped finding the ideal combination could slash death rates by 40 per cent.

The study will be the biggest of its kind for 20 years, lasting more than a decade and costing £42million, with £16m from the National Institute for Health and Care Research.

This is a pivotal moment in the history of prostate cancer research

Dr Matthew HobbsProstate Cancer …